Acurx Pharmaceuticals
Acurx scientific advisors include expertise in Non-clinical drug development, Infectious Diseases,
Epidemiology, Microbiology and Gastroenterology

Jack Dean, Ph.D., Sc.D.(Hon.), DABT, Fellow ATS: Founder, Drug Development Advisors; Research Professor, Medical
Pharmacology & Pharmacology/Toxicology, Colleges of Medicine & Pharmacy, University of Arizona, Tucson.  Previously, Head
Worldwide Preclinical Research and US Drug Development, Sanofi (including Special Advisor to President, R&D for Drug
Development, Drug Safety and Immunotoxicology

Richard Ellison, MD; Professor of Medicine, University of Massachusetts

Ellie Goldstein, MD: Clinical Professor of Medicine, UCLA Medical Center, Santa Monica

Stuart Johnson, MD: Professor of Medicine, Loyola University, Chicago; Co-Chair, 2017 Update IDSA/SHEA Clinical Practice
Guidelines for CDI

Ciaran Kelly, MD: Professor of Medicine, Harvard Medical School; Beth Israel Deaconess Medical Center; Member IDSA/SHEA
2017 Update Clinical Practice Guidelines Committee for CDI

Brad Spellberg, MD; Professor, Clinical Medicine; Associate Dean, Clinical Affairs, Keck School of Medicine, USC; Chief Medical
Officer, Los Angeles County-University of Southern California Medical Center.

George Wright, Ph.D.:  Professor of Pharmacology, University of Massachusetts, Medical School; Discoverer of ACX-362E